Table 1.
Baseline characteristics among men and women with HSA data.
| Analytic Sample | |||
|---|---|---|---|
|
| |||
| Variable | Men (n=137) |
Women (n=145) |
P Value |
| White (n, %) | 123 (90.5%) | 134 (93.7%) | 0.32 |
| Age (m, SD) | 80.3 ± 7.7 | 81.0 ± 7.7 | 0.48 |
| Weight (m, SD) | 79.5 ± 14.1 | 63.4 ± 14.3 | <0.0001 |
| Height (m, SD) | 1.8 ± 0.08 | 1.6 ± 0.08 | <0.0001 |
| Smoking (n, %) | |||
| Never | 30 (22.1%) | 67 (46.5%) | <0.0001 |
| Past | 95 (69.9%) | 68 (47.2%) | |
| Present | 11 (8.1%) | 9 (6.3%) | |
| Alcohol Use (n, %) | |||
| None | 53 (40.0%) | 72 (50.0%) | 0.089 |
| Minimal | 79 (58.1%) | 65 (45.1%) | |
| Moderate | 4 (2.9%) | 7 (4.9%) | |
| Bone-Active Drugs (n, %) | |||
| Never | 123 (91.1%) | 84 (58.3%) | <0.0001 |
| Past | 1 (0.7%) | 21 (14.6%) | |
| Current | 11 (8.2%) | 39 (27.1%) | |
| Glucocorticoids | |||
| Never | 106 (80.3%) | 91 (64.1%) | 0.009 |
| Past | 17 (12.9%) | 29 (20.4%) | |
| Current | 9 (6.8%) | 22 (15.5%) | |
| Hormone Therapy | 4 (2.9%) | 54 (37.5%) | <0.0001 |
| Calcium Supplements (n, %) | |||
| Never | 96 (71.1%) | 45 (31.5%) | <0.0001 |
| Past | 14 (10.4%) | 17 (11.9%) | |
| Current | 25 (18.5%) | 81 (56.6%) | |
| Comorbidity (M, IQR) | 2.5 ± 1.9 | 1.7 ± 1.6 | 0.0001 |
| IADL (M, IQR) | 2.2 ± 1.5 | 1.7 ± 1.5 | 0.0099 |
| CES-D (m, SD) | 17.0 ± 9.6 | 17.7 ± 11.2 | 0.55 |